The Ca2+/phospholipid/cytoskeletal-binding protein annexin II has been proposed to play an important role in Ca2+-dependent exocytosis; however, the evidence for this role is inconclusive. More direct evidence obtained by manipulating annexin II levels in cells is still required. We have attempted to do this by generating stably transfected PC12 cell lines expressing proteins which elevate or lower functional annexin II levels and using these cell lines to investigate Ca2+-dependent exocytosis. Three cell lines were generated: one expressing an annexin II mutant which aggregates annexin II in at least a proportion of the cells, thereby removing functional protein from the cell; a mixed clonal cell line constitutively overexpressing human annexin II; and a clonal cell line capable of overexpressinf annexin II in the presence of sodium butyrate. After digitonin permeabilization, Ca -dependent dopamine release from these cell lines was compared with that from control nontransfected cells, and, in addition, release was compared in induced to uninduced cells. There were no significant differences in Ca2'-dependent exocytosis between any of the transfected cell lines before or after induction and the control cells. In addition, nontransfected PC12 cells treated with nerve growth factor, which elevates annexin II levels severalfold, failed to increase Ca2+-dependent exocytosis after digitonin permeabilization, compared with control cells. We conclude that annexin II is not an important regulator of Ca2+-dependent exocytosis in PC12 cells.
INTRODUCTION
Annexin II (also known as calpactin 1, lipocortin II, and chromobindin 8) is a member of the annexin family of Ca2+-binding proteins ). It can exist as a monomer of 36 KDa (also known as p36) and as a heterotetramer formed from two subunits of annexin II bound to two subunits of an 11-kDa protein called pll which belongs to the S-100 family of proteins. The heterotetramer is localized at the cytoplasmic face of the plasma membrane and/or the submembranous cytoskeleton (Greenberg and Edelman, 1983; Zokas and Glenney, 1987; Semich et al., 1989) , whereas monomeric annexin II appears to be predominantly a cytosolic protein (Zokas and Glenney, 1987; Thiel et al., 1992) . bring about the aggregation and fusion of secretory vesicles at high Ca + concentrations, but annexin II only requires low physiological Ca2+ concentrations for the same effect (Drust and Creutz, 1988) . In the presence of arachidonic acid and Mg2+, chromaffin granule membranes aggregated by annexin II can undergo fusion (Drust and Creutz, 1988) . In addition, in mammary cells annexin II is localized to the apical membrane where secretion of milk proteins occurs (Handel et al., 1991) . More direct evidence involving functional studies with permeabilized cells have also supported the hypothesis of an important role for annexin II in exocytosis. Digitonin-permeabilized chromaffin cells leak proteins essential for exocytosis, including annexin II, leading to a loss of ability to secrete in response to Ca2+, a phenomenon known as run-down. Permeabilized cells incubated with exogenous annexin II showed a two-to threefold increase in exocytosis above that seen in the absence of added annexin II, upon subsequent stimulation with 10 ,tM Ca2+ (Ali et al., 1989) .
The reconstitution assays with permeabilized cells, although valuable, have limitations. As run-down is allowed to proceed, the ability of annexin II to stimulate exocytosis is diminished (Ali and Burgoyne, 1990; Burgoyne and Morgan, 1990; Sarafian et al., 1991) , suggesting that other proteins essential for exocytosis have been lost. Another means of manipulating annexin II levels in intact cells is required to provide stronger evidence of an important role for annexin II in Ca2+-dependent exocytosis. We have chosen to study the role of annexin II in PC12 cells since these cells normally express very low levels of the protein unless neuronal differentiation is induced by nerve growth factor (NGF)1 treatment (Schlaepfer and Haigler, 1990) . PC12 cells should therefore provide a good model system for attempts to reduce functional annexin II levels or for examination of the consequences of overexpression. The approach we have used here involves stably transfecting PC12 cells with expression constructs encoding proteins that elevate or lower levels of functional annexin II. We have produced PC12 cell lines expressing a trans-dominant annexin II mutant (Harder and Gerke, 1993) Harder and Gerke, 1993) . The cDNA encoding human annexin II with the replacement of Ala65 by glutamic acid (known as A65E) was originally cloned into the pCMV5 expression vector (Thiel et al., 1992) . This insert was excised using restriction endonucleases EcoRI and XbaI and ligated into the EcoRI/XbaI-linearized pcDNA3 expression vector. The vector possesses the neomycin-resistance gene and the human cytomegalovirus (CMV) promoter. The resulting plasmid is referred to as pcDNA3 AnxII.
Transfections
Transfected PC12 cell lines were generated by electroporation using a Progenitor II PG200 (Hoefer, San Francisco, CA) at 1080 ,uF, 260 V, and three discharges per sample in a 0.4-cm cuvette in the presence of pLKXM or pcDNA3 AnxII (linearized with XbaI and BglII restriction enzymes, respectively). For electroporation, PC12 cells in suspension were dissociated with trypsin, and 1 ml of media containing 5 x 106 cells was placed in an electroporation cuvette with 10 ,g of plasmid. After electroporation cells were rapidly diluted in fresh media to a density of 0.5 x 106/ml and then plated into collagencoated 6-cm tissue culture Petri dishes. The following day the medium was replaced by fresh medium initially containing 500 ,g/ml G418 sulfate but subsequently containing 400 ,ug/ml. Fresh media and G418 were added as required. Resistant Cells were cultured in 24-well trays for at least 3 d before assaying and were induced to express protein by the addition of dexamethasone (MMTV promoter-inducing agent), sodium butyrate (CMV promoter-inducing agent) overnight, or with a 5-h treatment with sodium butyrate followed by overnight incubation which was as effective as the continuous presence of sodium butyrate immediately before assaying. Assays involving a comparison between different cell types or treatments were always performed within one 24-well tray. PC12 cells were labeled for 2 h in RPMI 1640 containing 0.5 ,uCi of [7,8-3H] dopamine and 0.5 mM ascorbic acid. After labeling, cells were washed three times in Krebs-Ringer buffer (145 mM NaCl, 5 mM KCl, 1.3 mM MgCl2, 1.2 mM NaH2PO4, 10 mM glucose, 20 mM HEPES, 3 mM CaCl2 at pH 7.4). Cells in each well were permeabilized by the addition of 300 ,ul of permeabilization buffer (139 mM potassium glutamate, 5 mM EGTA, 20 mM PIPES, 2 mM ATP, 2 mM MgCl2, 20 ,uM digitonin at pH 6.5) for 6 min. After the removal of the permeabilization buffer, cells were challenged by the addition of buffer with either 0 Ca2+ or with 10 ,AM free Ca2+ in the absence of digitonin. After stimulation for 5 or 15 min, the challenge buffer was removed, spun for 1 min at high speed in a microcentrifuge, and supernatant samples were counted in duplicate in a scintillation counter. Total dopamine content of the cells was determined by release with 1% Triton X-100. Released dopamine was calculated as a percentage of total cellular dopamine. All experiments were performed at room temperature. Each treatment was performed at least in triplicate wells per tray.
Electrophoresis and Western Blotting
The chimeric annexin II-pll derivative and the A65E annexin II protein were detected in transfected cells by Western blotting. Cells were plated out and incubated with inducers overnight as described for the dopamine release assay. Cells were washed twice with Krebs-Ringer buffer and then solubilized in SDS-PAGE dissociation buffer (150 ,ul/well) . Cell samples were run on 15% acrylamide gels and then transferred to nitrocellulose paper. Transfer buffer containing 40% methanol (as opposed to the usual 20% methanol) in Tris-glycine (pH 8.6) was used to transfer the pll subunit and the chimeric protein. Nitrocellulose paper was incubated in phosphatebuffered saline (PBS) containing 3% powdered milk for 45 min followed by the primary antibody diluted in PBS plus 3% powdered milk for 1 h. The monoclonal antibodies H21 (for pl1) and H28 (for human A65E annexin II) were used at a 1:1000 (Osborn et al., 1988) dilution, and the HH7 monoclonal (for rat annexin II and human A65E annexin II) was used at a 1:200 dilution (Thiel et al., 1992) . Anti-mouse peroxidase at a 1:400 dilution in PBS plus 3% powdered milk and 0.5% Tween 20 was used for second antibody incubations for 1 h. The reaction was visualized using enhanced chemiluminescence (Amersham).
Immunofluorescence
Trypsin-dissociated PC12 cells were plated at a density of 0.1 X 106 cells/well onto collagen-coated glass coverslips in 24-well trays and induced with dexamethasone and sodium butyrate as described previously. At 3 d in vitro, cells were fixed with 3.7% formaldehyde in PBS. Cells were permeabilized by incubation in 0.1% Triton X-100 and 0.3% bovine serum albumin in PBS (PBT) for 30 min. Incubation with the primary antibody was for 1 h at a 1:50 dilution in PBT for both H21 and HH7 antibodies. The second incubation was for 1 h with anti-mouse Ig (biotinylated) at a 1:100 dilution in PBT followed by Texas Red streptavidin at 1:50 in PBT for 30 min.
RESULTS

Generation of a Stably Transfected Cell Line
Expressing the Chimeric Annexin II-pll Protein A chimeric annexin 11-pll cDNA coding for the NH2-terminal domain (residues 1-18) of annexin II fused to the NH2-terminus of the entire human pll chain was transfected into PC12 cells using the pLK expression vector, which contains the cDNA insert under the control of the dexamethasone-inducible MMTV promoter (Hirt et al., 1992; Harder and Gerke, 1993) . A neomycin-resistant, stably transfected clone displaying dexamethasone-inducible expression of the chimeric protein was isolated. The chimeric protein (XM) was detected by Western blotting using the monoclonal antibody H21 (Osborn et al., 1988) , which recognizes the human pll component of XM but does not cross-react with the endogenous rat pll of PC12 cells ( Figure 1 ). Figure 1 also reveals that the expression of XM is increased 2.3-fold by dexamethasone treatment. Western blotting of the PC12-XM cells with HH7 antibody (which detects endogenous rat annexin II) showed that levels of annexin II were also increased compared with control PC12 cells (and other transfected PC12 cell lines not expressing the XM protein; our unpublished observations; Figure 1 ), suggesting that XM expression stimulated annexin II overexpression. However, in contrast to the levels of the XM protein the expression of endogenous annexin II was not further increased following dexamethasone treat- The chimeric protein contains the entire pl1-binding domain of annexin II [i.e., amino acids 1-14 ] fused to the NH2-terminus of the whole pll protein. This allows for three binding sites, i.e., a pll-binding site in the NH2-terminal annexin II domain, a pll-binding site in the pll chain (dimerization), and an annexin II-binding site in the pll chain (Harder and Gerke, 1993) . High expression of XM thus leads to the formation of aggregates containing endogenous annexin II and pll in addition to the chimeric protein. This should result in a sequestration of annexin II and pll, removing them from the functional pool. Immunofluorescence studies of PC12-XM cells using the HH7 antibody indeed showed the presence of large annexin II aggregates in a proportion (10-20%) of the cells after dexamethasone induction (Figure 2) . These results are similar to those found previously in other cell lines, especially 208F rat fibroblasts and MDCK cells, although the fraction of transfected cells containing visible aggregates is somewhat higher in the latter cases (Harder and Gerke, 1993) .
The annexin II monomer and/or the heterotetramer, i.e., annexin II-pll complex are thought to play a role in regulated exocytosis since the purified proteins partially retard secretory run-down in permeabilized bovine chromaffin cells (Ali et al., 1989) . The chimeric protein can be considered to be a trans-dominant mutant of the annexin II-pll heterotetramer (Harder and Gerke, 1993) ; therefore, secretion studies using the PC12-XM cell line would be useful to investigate the role of annexin II in Ca2+-dependent exocytosis in PC12 cells. PC12-XM cells and control PC12 cells were incubated overnight with the MMTV inducer, dexamethasone (1 ,uM). To examine Ca2+-dependent exocytosis directly, the cells were then briefly permeabilized with digitonin before stimulation with 0 or 10 ,tM Ca2+. The permeabilized cells were assayed for Ca2+-dependent dopamine exocytosis over 5 min or 15 min. These data are shown in Figure 3A . Both cell types displayed Ca2+-stimulated exocytosis at the two time points. The basal levels of release of dopamine were lower for the PC12-XM cell line but the extent of Ca2+-dependent release of dopamine is similar for the PC12-XM and control cells at both time points. Since only a single XM-expressing cell line was available, we attempted to rule out problems due to clonal differences by using the PC12-XM cell line as its own control by comparing exocytosis with or without induction by dexamethasone. As shown in Figure 3B , essentially identical levels of exocytosis were seen with or without induction of the chimeric protein after overnight or 2-d treatment with dexamethasone. These results suggest that disrupting the normal annexin II distribution by expression of the chimeric protein has little effect on Ca"f-dependent secretion. It should be noted however that annexin II aggregates were only clearly observed in a proportion of the cells.
Production of Stably Transfected PC12 Cells which Overexpress Human A65E Annexin II PC12 cells were transfected with the pcDNA3 AnxII plasmid and stably transfected clones were selected in the presence of neomycin. The annexin II cDNA coded for human p36 with the substitution of alanine 65 by glutamic acid (A65E; Thiel et al., 1992) . This substitution allowed the transfected protein to be detected with H28 monoclonal antibody [H28 does not detect Molecular Biology of the Cell rodent or wild-type human annexin II (Osborn et al., 1988) ], which recognizes a discontinuous epitope with a crucial residue at position 65. The presence of Glu at this site is essential for H28 immunoreactivity . The A65E mutation does not alter the biochemical properties of annexin II (Thiel et al., 1991) .
Selection of a clonal cell line can be problematical since any observed differences may be due to clonal differences rather than expression of the transfected protein. We attempted to overcome this problem by initially making populations of stably transfected cells containing a mixture of clones. All of the mixtures isolated expressed high levels of human A65E annexin II as detected by Western blotting using the H28 antibody. None could be induced to significantly increase expression after sodium butyrate treatment which has previously been used to enhance expression from the CMV promoter (Gorman et al., 1983) . We wished to establish whether the levels of annexin II expressed in transfected cells were comparable to those seen due to physiological stimulation. NGF is known to elevate annexin II levels significantly in PC12 cells (Schlaepfer and Haigler, 1990) . Transfected PC12 cells were incubated overnight in the presence or absence of sodium butyrate, and control nontransfected cells were incubated for 3 d with or without NGF (100 ng/ml). Expression of total annexin II (endogenous rat plus transfected human) was investigated by Western blotting with the HH7 antibody. Similar levels of annexin II were found in both the NGF-treated control cells and transfected cells (i.e., around 2.9-fold above control levels), although sodium butyrate treatment did not increase expression of annexin II in the transfected cells ( Figure 4A ). Im under more physiological conditions. Western blotting with the HH7 antibody to detect total annexin II ( Figure 7) showed that, in this experiment, sodium butyrate increased expression by 4.6-fold to levels similar to those found after 1 d of NGF treatment (4.1-fold above control levels).
The distribution of total annexin II in C6 cells was examined by immunofluorescence, both before and after sodium butyrate treatment and compared with control nontransfected cells given the same treatment. As expected, the levels of annexin II in PC12-C6 cells increased in response to sodium butyrate as shown by markedly brighter fluorescence staining (Figure 8 ), but in addition there was also a marked apparent translocation of immunoreactivity from the cytoplasm to the plasma membrane (Figure 8d ) as previously noted for the mixed clonal cells overexpressing annexin II. This phenomenon was also observed in control PC12 cells treated with NGF (our unpublished observations). Sodium butyrate did not affect the intensity or localization of immunofluorescence in control cells (Figure 8 , a and b).
(lane e) compared with cells with no additions (N/A, lanes a and b) . The level of increased annexin II expression in the sodium butyrate cells was similar to that seen in response to NGF for 1 d.
The release of dopamine from the clonal PC12-C6 cell line after sodium butyrate treatment was compared with that from similarly treated control nontransfected PC12 cells. The percentage of increase in secretion over basal due to Ca2+ stimulation from permeabilized cells was not significantly different between the two cell lines, after either a 5-min (our unpublished observations) or 15-min stimulation (Figure 9A ). Since annexin II was inducible in the PC12-C6 cells, we were also able to use these cells as their own controls to avoid problems of interpretation due to clonal variation. Release of dopamine was compared in cells with or without treatment with sodium butyrate. Induction of annexin II overexpression did not affect the extent of release found ( Figure 9B ). These results show that an acute increase in annexin II levels does not affect Ca2+-dependent exocytosis in permeabilized PC12 cells.
Release of Dopamine from Control Nontransfected PC12 Cells Treated with NGF Treatment of PC12 cells with NGF leads to a prolonged elevation of annexin II levels (Schlaepfer and Haigler, 1990 , and confirmed here in Figures 4 and 7) . Although NGF is known to induce differentiation of PC12 cells to a more neuronal-like phenotype, the PC12 cell line used in the present secretion studies shows little change in morphology and little neurite outgrowth. NGF treatment therefore can be used as an additional model for investigating the effects of a rise in annexin II upon PC12 cell exocytosis. Nontransfected PC12 cells were treated with 100 ng/ml NGF for 4 d. Ca2+-dependent dopamine release after digitonin permeabilization was compared with the same cells not given NGF. Ca2+-dependent dopamine release over 5 and 15 min was slightly reduced in the NGF-treated cells compared with the control cells (Figure 10 ). This result provides further evidence that an elevation of annexin II does not increase Ca21-dependent exocytosis from PC12 cells. 
DISCUSSION
The strategy used here was to generate stably transfected PC12 cell lines showing an altered expression or intracellular localization of annexin II to allow assessment of the function of the protein in Ca 2+-dependent exocytosis. Similar strategies have been successfully used to demonstrate a role in exocytosis in PC12 cells for rab3A and rab3B using stable transfections (Weber et al., 1996) , and rabphilin and Doc2 using transient transfections, indicating the validity of this approach in the present study.
2+
Annexin II was thought to play a role in Cadependent exocytosis, although much of the evidence for this was indirect. The major functional evidence for a role in exocytosis has come from studies using permeabilized chromaffin cells in which secretory rundown is retarded by the addition of exogenous annexin II or the heterotetramer, i.e., the annexin II-pll complex (Ali et al., 1989; Sarafian et al., 1991) . Recently, it has been suggested that annexin II is essential for exocytosis in intact chromaffin cells based on its translocation to the plasma membrane on stimulation and an inhibitory effect of a synthetic peptide (ChasserotGolaz et al., 1996) . The peptide was derived from the sequence surrounding the protein kinase C phosphorylation site and, therefore, could simply have been acting as an inhibitor of protein kinase C rather than a specific inhibitor of annexin II function.
In this study, we set out to manipulate annexin II levels in intact cells. In PC12 cells in culture, the addition of NGF can elevate annexin II many fold from an initial low level of expression (0.02% of cellular protein) (Schlaepfer and Haigler, 1990 The reconstitution of secretion assay in permeabilized chromaffin and PC12 cells has been used to identify several proteins involved in the regulation of exocytosis. To date, annexin II (Ali et al., 1989; Sarafian et al., 1991), 14-3-3 proteins (Morgan and Burgoyne, 1992) , calmodulin (Chamberlain et al., 1995) , phosphatidylinositol transfer protein (Hay and Martin, 1993) , phosphatidylinositol-4-phosphate 5-kinase (Hay et al., 1995) , protein kinase C (Morgan and Burgoyne, 1992) , protein kinase A , and a-soluble NSF-attachment protein have been identified as stimulators of permeabilized chromaffin or PC12 cell exocytosis. In another report, however, the reconstituting ability of cytosol was found to be unaffected by annexin II depletion (Wu and Wagner, 1991) . The main stimulatory component of run-down reconstituting cytosol in chromaffin cells was identified as Exol, which turned out to be a family of 14-3-3 proteins (Morgan and Burgoyne, 1992) , and immunodepletion of these proteins from cytosol did reduce its reconstituting ability (Wu et al., 1992 ). 14-3-3 proteins stimulate exocytosis by reorganization of the cortical actin cytoskeleton that normally acts as a barrier to exocytosis, thus allowing increased availability of secretory granules for release . One of the domains conserved in the entire range of the 14-3-3 proteins is homologous to the C terminus of the annexins and is most similar to annexin II (Aitken et al., 1990) . The failure to demonstrate a major role for annexin II in transfected PC12 cell exocytosis leads us to speculate that the annexin II effects observed in run-down chromaffin cells may be due to annexin II mimicking the effects of 14-3-3 proteins. Indeed a 16-residue synthetic peptide based on the common annexin II/14-3-3 protein domain partially inhibited Ca2+-dependent exocytosis in permeabilized chromaffin cells (Roth et al., 1993) .
It may be possible that in the permeabilized chromaffin cell run-down assay, annexin II is simply delaying the loss of other factors required for exocytosis rather than exerting a direct stimulatory effect itself, since its major effect is to retard run-down and it is not stimulatory when added at later times of run-down (Ali and Burgoyne, 1990; Burgoyne and Morgan, 1990) . A difference in cell type between chromaffin and PC12 cells also cannot be ruled out as a possibility for the different effects of annexin II on exocytosis. It has not been possible to repeat the annexin II reconstitution of run-down observed in permeabilized chromaffin cells in PC12 cells, since in our hands digitoninpermeabilized PC12 cells do not exhibit the run-down phenomenon. Other laboratories have reported similar findings (Wagner et al., 1993) . PC12 cells permeabilized by cell cracking do exhibit run-down, which can be reconstituted by a Ca2+-and ATP-dependent protein called p145, purified from brain cytosol (Walent et al., 1992) .
PC12-C6 cells induced with sodium butyrate (as well as the mixed clonal cell population overexpressing annexin II) exhibit a translocation of annexin II immunoreactivity from the cytoplasm to the plasma membrane. If annexin II had a major role in Ca21-dependent exocytosis, we would expect induced PC12-C6 cells to show a marked increase in Ca21-dependent dopamine release due to its increased expression localized at the site of exocytosis. This was not the case, no difference in the extent of exocytosis in induced compared with uninduced PC12-C6 cells was observed and thus further indication that annexin II is not a major regulator of Ca2+-dependent exocytosis in these cells.
The data presented here suggest that annexin II is not likely to have a major role in Ca 2'-dependent exocytosis leading to dopamine release from PC12 cells, since manipulations leading to a decrease or an increase in functional annexin II levels, including an increase in the plasma membrane localization of annexin II, were without effect on the extent of release. Nevertheless, the stably transfected cell lines generated here may be useful for the study of other suggested functions of annexin II.
